Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention For ST-Segment Elevation Myocardial Infarction In Patients ≥ 70 Years of Age
This study compared efficacy and safety of PI with primary percutaneous coronary intervention (pPCI). Data from 2841 patients (mean age: 78.1±5.6 years, fema le: 36.1%) included in a prospective multicenter registry, and who underwent either PI (n=269) or pPCI (n=2572), were analyzed. The primary endpoint was in-hospital major adverse cardiovascular events (MACE) defined as the composite of all-cause mortality, non-fatal MI, stroke and definite stent thr ombosis.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Vincent Auffret, Cl ément Laurin, Guillaume Leurent, Romain Didier, Emmanuelle Filippi, Jean-Philippe Hacot, Amer Zabalawi, Gilles Rouault, Djamel Saouli, Philippe Druelles, Isabelle Coudert, Bertrand Boulanger, Emilie Bot, Josiane Treuil, Marc Bedossa, Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Heart Attack | Hospitals | Men | Percutaneous Coronary Intervention | Stroke | Study